Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aptamer Sciences, Inc.

Clinical trials sponsored by Aptamer Sciences, Inc., explained in plain language.

Trials to join now! 1

New hope for Hard-to-Treat cancers: first human trial of AST-201 begins

Disease control Recruiting now

This study tests a new drug called AST-201 in people with advanced solid tumors that have a protein called GPC3. The main goal is to check the drug's safety and find the right dose. About 70 adults with liver or lung cancer that has not responded to other treatments will take par…

Phase: PHASE1 • Sponsor: Aptamer Sciences, Inc. • Aim: Disease control

Last updated May 22, 2026 13:50 UTC